As of 2026-06-26, Telomir Pharmaceuticals, Inc. Common Stock (TELO) has a 3-month relative strength percentile of 37 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 44. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.4%, relative volume 0.36×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
TELO ranks at the 38th percentile over 1 month, 37th percentile over 3 months, 36th percentile over 6 months, 24th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
TELO is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data.
Sector RS percentile is not available for Healthcare at this snapshot. Leading sector status (threshold: Healthcare RS ≥ 70th percentile) cannot be determined until the next sector RS pipeline run.
TELO currently shows a 20-day average daily range (ADR%) of 5.4%, a 90-day beta versus the S&P 500 of 2.03. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
TickerStance computes TELO's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what TELO has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.
TELO most recently filed a 10-Q covering FY26 Q1 with the SEC on 2026-05-14. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.
§ Seasonality
10y · since 2024
Best monthFebon averageavg +25.04% · 67% win · n 3
Worst monthJunon averageavg -28.11% · 0% win · n 2
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
+1.8%
+25.0%
-20.0%
+5.1%
-13.2%
-28.1%
+12.3%
+7.9%
+13.9%
-12.3%
-8.0%
+1.4%
TELO monthly seasonality strip
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
1
TELO Jan
avg: 1.84%
median: 1.84%
win: 50%
σ: 22.80%
n: 2
2024-02-12 → 2026-05-29
TELO Feb
avg: 25.04%
median: 11.40%
win: 67%
σ: 50.93%
n: 3
2024-02-12 → 2026-05-29
TELO Mar
avg: -20.04%
median: -19.25%
win: 33%
σ: 22.80%
n: 3
2024-02-12 → 2026-05-29